Search
CLOSENews
Newsroom
The second EU Joint Action on Networks of Expertise on Cancer JANE-2 (2024-2028), involves 133 organizations from 29 European countries. It is coordinated by Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Italy, and co-funded by the European Union with 40.5 million EUR.
JANE-2 project aims at building seven Networks of Expertise (NoEs) in the area of oncology that will transform the way cancer care will be delivered at EU level.
NanoMito
Biological assessment of the toxicity of nanosystems in the nematode Caenorhabditis elegans and evaluation of their potential to extend healthspanThe National Hellenic Research Foundation participates in the funded European Project “Universal Platform Components for Safe Fair Interoperable Data Exchange, Monetisation and Trading” (Acronym: UPCAST), which provides a set of universal, trustworthy, transparent and user-friendly data market plugins for the automation of data sharing and processing agreements between businesses, public administrations and citizens.
The second Joint Action (JA) of the EU on Networks of Expertise on Cancer (JANE-2) was launched in Milan, Italy, on January 28-29, 2025. The project is a follow-up of the JA JANE (2022-2024) (https://jane-project.eu) and is coordinated by Italy through the Fondazione IRCCS Istituto Nazionale Tumori in Milan, involving 121 partners from 29 European countries and co-financed by the European Union (EU) with 40.5 million euros. Greece is represented in JANE-2 by the National Hellenic Research Foundation (NHRF) and the National and Kapodistrian University of Athens (NKUA) as participating institutions.
Organised in the context of the COST ACTION 2111-OneHealthdrugs – “One Health drugs against parasitic vector borne diseases in Europe and beyond” https://onehealthdrugs.com/.
The workshop seeks to provide up to date information and integration strategy on sustainable drug discovery for vector borne diseases (VBDs). Special emphasis will also be given to new targets for VBDs and methods to study their engagement as well as on biodegradability and toxicity aspects pinpointing the effect on the environment.
The event is open to PhD, young innovators and senior scientists from both academia and pharma.
News Feed
Ημερομηνία ανάρτησης: January 20, 2026
Καταληκτική ημερομηνία υποβολής υποψηφιοτήτων: February 28, 2026, 23:59
SusDrugs4VBD
The second EU Joint Action on Networks of Expertise on Cancer JANE-2 (2024-2028), involves 133 organizations from 29 European countries. It is coordinated by Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Italy, and co-funded by the European Union with 40.5 million EUR.
JANE-2 project aims at building seven Networks of Expertise (NoEs) in the area of oncology that will transform the way cancer care will be delivered at EU level.
The National Hellenic Research Foundation participates in the funded European Project “Universal Platform Components for Safe Fair Interoperable Data Exchange, Monetisation and Trading” (Acronym: UPCAST), which provides a set of universal, trustworthy, transparent and user-friendly data market plugins for the automation of data sharing and processing agreements between businesses, public administrations and citizens.
Twin4Promis
NerveRepack
PuDeRegels
BIOKARETRA
The second Joint Action (JA) of the EU on Networks of Expertise on Cancer (JANE-2) was launched in Milan, Italy, on January 28-29, 2025. The project is a follow-up of the JA JANE (2022-2024) (https://jane-project.eu) and is coordinated by Italy through the Fondazione IRCCS Istituto Nazionale Tumori in Milan, involving 121 partners from 29 European countries and co-financed by the European Union (EU) with 40.5 million euros. Greece is represented in JANE-2 by the National Hellenic Research Foundation (NHRF) and the National and Kapodistrian University of Athens (NKUA) as participating institutions.
ENHANCE-SKIN
Organised in the context of the COST ACTION 2111-OneHealthdrugs – “One Health drugs against parasitic vector borne diseases in Europe and beyond” https://onehealthdrugs.com/.
The workshop seeks to provide up to date information and integration strategy on sustainable drug discovery for vector borne diseases (VBDs). Special emphasis will also be given to new targets for VBDs and methods to study their engagement as well as on biodegradability and toxicity aspects pinpointing the effect on the environment.
The event is open to PhD, young innovators and senior scientists from both academia and pharma.
The National Hellenic Research Foundation (NHRF) participates in the implementation of the “EU Joint Action on Networks of Expertise”. Within a 2-year period, JANE aims to establish seven new Networks of Expertise (NoEs) in the cancer field, able to function effectively, building on previous and ongoing EU networking experiences, and finding solutions rooted in the European oncology community.
Health Hub ΕΙΕ
Archimedes Center and the National Hellenic Research Foundation are happy to announce that Associate Professor Vassiliki Iconomidou (Molecular Biophysics & Bioinformatics) of the Department of Biology of the National & Kapodistrian University of Athens and Research Director Niki Chondrogianni (Molecular & Cellular Ageing) of the ICB of NHRF, have just patented a groundbreaking invention in the fight against Alzheimer’s Disease.
3GPV-4INDUSTRY
Nano-Applications
PROTEOSTASIS
METABOTHYRO
